Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Miyoshi

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Geriatrics & Gerontology International|July 1, 2022
The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8): A cross-sectional study of elderly patients with diabetesAika Miya, Akinobu Nakamura, Isao Yokota, et al.
Cardiovascular Diabetology|October 12, 2017
The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)Naoyuki Kitao, Hideaki Miyoshi, Tomoo Furumoto, et al.
Plos One|November 25, 2010
Perilipin overexpression in white adipose tissue induces a brown fat-like phenotypeTakashi Sawada, Hideaki Miyoshi, Kohei Shimada, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2012
Autoimmune pancreatitis with histologically proven lymphoplasmacytic sclerosing pancreatitis with granulocytic epithelial lesionsTsukasa Ikeura, Makoto Takaoka, Kazushige Uchida, et al.
Diabetes, Obesity & Metabolism|October 27, 2021
Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db miceShinichiro Kawata, Akinobu Nakamura, Hideaki Miyoshi, et al.
Diabetes Research and Clinical Practice|September 26, 2021
Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study)Reina Hashimoto-Kameda, Kyu Yong Cho, Hiroshi Nomoto, et al.
International Journal of Rheumatology|April 27, 2012
Regulatory T cells in type 1 autoimmune pancreatitisKazushige Uchida, Takeo Kusuda, Masanori Koyabu, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 25, 2021
Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)Hiroshi Nomoto, Chiho Oba-Yamamoto, Yuka Takahashi, et al.
The Journal of Biological Chemistry|April 6, 2006
Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanismsHideaki Miyoshi, Sandra C Souza, Hui-Hong Zhang, et al.
Diabetes, Obesity & Metabolism|September 6, 2019
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study)Kyu Yong Cho, Hiroshi Nomoto, Akinobu Nakamura, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Geriatrics & Gerontology International|July 1, 2022
The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8): A cross-sectional study of elderly patients with diabetesAika Miya, Akinobu Nakamura, Isao Yokota, et al.
Cardiovascular Diabetology|October 12, 2017
The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)Naoyuki Kitao, Hideaki Miyoshi, Tomoo Furumoto, et al.
Plos One|November 25, 2010
Perilipin overexpression in white adipose tissue induces a brown fat-like phenotypeTakashi Sawada, Hideaki Miyoshi, Kohei Shimada, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2012
Autoimmune pancreatitis with histologically proven lymphoplasmacytic sclerosing pancreatitis with granulocytic epithelial lesionsTsukasa Ikeura, Makoto Takaoka, Kazushige Uchida, et al.
Diabetes, Obesity & Metabolism|October 27, 2021
Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db miceShinichiro Kawata, Akinobu Nakamura, Hideaki Miyoshi, et al.
Diabetes Research and Clinical Practice|September 26, 2021
Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study)Reina Hashimoto-Kameda, Kyu Yong Cho, Hiroshi Nomoto, et al.
International Journal of Rheumatology|April 27, 2012
Regulatory T cells in type 1 autoimmune pancreatitisKazushige Uchida, Takeo Kusuda, Masanori Koyabu, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 25, 2021
Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)Hiroshi Nomoto, Chiho Oba-Yamamoto, Yuka Takahashi, et al.
The Journal of Biological Chemistry|April 6, 2006
Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanismsHideaki Miyoshi, Sandra C Souza, Hui-Hong Zhang, et al.
Diabetes, Obesity & Metabolism|September 6, 2019
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study)Kyu Yong Cho, Hiroshi Nomoto, Akinobu Nakamura, et al.
Pageof 16